Edition:
India

Ocular Therapeutix Inc (OCUL.OQ)

OCUL.OQ on NASDAQ Stock Exchange Global Market

5.33USD
14 Dec 2018
Change (% chg)

$-0.31 (-5.50%)
Prev Close
$5.64
Open
$5.64
Day's High
$5.64
Day's Low
$5.29
Volume
93,669
Avg. Vol
105,469
52-wk High
$8.26
52-wk Low
$4.30

Chart for

About

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Its lead product candidate, DEXTENZA (dexamethasone insert) for intracanalicular use, has completed Phase... (more)

Overall

Beta: --
Market Cap(Mil.): $181.90
Shares Outstanding(Mil.): 29.06
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates